Your browser doesn't support javascript.
loading
Phase II trial of single-agent panobinostat consolidation improves responses after sub-optimal transplant outcomes in multiple myeloma.
Mithraprabhu, Sridurga; Kalff, Anna; Gartlan, Kate H; Savvidou, Ioanna; Khong, Tiffany; Ramachandran, Malarmathy; Cooke, Rachel E; Bowen, Kathryn; Hill, Geoffrey R; Reynolds, John; Spencer, Andrew.
Afiliación
  • Mithraprabhu S; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.
  • Kalff A; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia.
  • Gartlan KH; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.
  • Savvidou I; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia.
  • Khong T; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Ramachandran M; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.
  • Cooke RE; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia.
  • Bowen K; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.
  • Hill GR; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia.
  • Reynolds J; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia.
  • Spencer A; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia.
Br J Haematol ; 193(1): 160-170, 2021 04.
Article en En | MEDLINE | ID: mdl-32945549
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante Autólogo / Inhibidores de Histona Desacetilasas / Panobinostat / Mieloma Múltiple Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2021 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante Autólogo / Inhibidores de Histona Desacetilasas / Panobinostat / Mieloma Múltiple Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2021 Tipo del documento: Article País de afiliación: Australia